113 related articles for article (PubMed ID: 9757685)
1. [Practical implications of bacterial resistance to antibiotics. Attempts to fight it].
Denys A
Otolaryngol Pol; 1997; 51 Suppl 25():171-4. PubMed ID: 9757685
[TBL] [Abstract][Full Text] [Related]
2. [Resistance of respiratory tract infection agents is still increasing. Is its time for new antibiotic strategies?].
MMW Fortschr Med; 2003 Feb; 145(9):55. PubMed ID: 12666535
[No Abstract] [Full Text] [Related]
3. [Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. c. Combinations of beta-lactam antibiotics and beta-lactamases inhibitors].
Tamura M; Ito T
Nihon Rinsho; 1987 Mar; 45(3):583-7. PubMed ID: 3037135
[No Abstract] [Full Text] [Related]
4. [Prescription of antibiotics in acute respiratory infections].
Pérez Caballero MC; Gimeno LA; Sánchez Celaya M; Cañas JM; Aznar MP; Guillén A
Aten Primaria; 1996 Apr; 17(6):425-6. PubMed ID: 8672650
[No Abstract] [Full Text] [Related]
5. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
Hou F; Li J; Gao L; Chen Y
Chin Med J (Engl); 1998 Nov; 111(11):1039-43. PubMed ID: 11189212
[TBL] [Abstract][Full Text] [Related]
6. Dosing of amoxicillin/clavulanate for treatment of lower respiratory tract infection.
Natsch S; van der Meer JW
Clin Infect Dis; 1998 Feb; 26(2):529-30. PubMed ID: 9502501
[No Abstract] [Full Text] [Related]
7. [Usefulness of an amoxicillin/clavulanic-acid combination in respiratory tract infection: bacterial resistance and antibiotic therapy].
Caramia M; Taddei G; Nobilini A
Minerva Pediatr; 1990; 42(1-2):29-34. PubMed ID: 2186263
[TBL] [Abstract][Full Text] [Related]
8. Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use.
Brogden RN; Carmine A; Heel RC; Morley PA; Speight TM; Avery GS
Drugs; 1981 Nov; 22(5):337-62. PubMed ID: 7037354
[TBL] [Abstract][Full Text] [Related]
9. Amoxycillin/clavulanic acid prophylaxis in elective colorectal surgery.
Byrne DJ
J Hosp Infect; 1998 Apr; 38(4):319-20. PubMed ID: 9602980
[No Abstract] [Full Text] [Related]
10. [Treatment of community acquired acute uncomplicated pyelonephritis].
Pigrau C; Pahissa A
Med Clin (Barc); 1999 Apr; 112(14):558-9. PubMed ID: 10363249
[No Abstract] [Full Text] [Related]
11. Enhanced effects of amoxycillin/clavulanic acid compared with amoxycillin and clavulanic acid alone on the susceptibility to immunodefenses of a penicillin-resistant strain of Streptococcus pneumoniae.
Cuffini AM; Tullio V; Ianni Palarchio A; Bonino A; Paizis G; Carlone NA
Drugs Exp Clin Res; 1998; 24(4):173-84. PubMed ID: 10051963
[TBL] [Abstract][Full Text] [Related]
12. [Pneumococcal infections: penicillin resistance and therapeutic implications].
Kamoun A; Ben Hassen A; Mahjoubi F; Ben Redjeb S
Tunis Med; 1995 Feb; 73(2):119-23. PubMed ID: 9506153
[No Abstract] [Full Text] [Related]
13. [Progress in chemotherapeutic agents--beta-lactam antibiotics and beta-lactamase inhibitors].
Uzuka Y; Matsumoto K
Nihon Rinsho; 1986 Apr; 44(4):824-30. PubMed ID: 3531574
[No Abstract] [Full Text] [Related]
14. In vitro study to compare sensitivity of amoxicillin+clavulanic acid and cefpodoxime+clavulanic acid among beta-lactamase positive clinical isolates of gram-positive and gram-negative pathogens.
Pal RB; Pal P; Jain S; Kulkarni KP
J Indian Med Assoc; 2008 Aug; 106(8):545-8. PubMed ID: 18975519
[TBL] [Abstract][Full Text] [Related]
15. Amoxicillin/clavulanate therapy of respiratory tract infections: a microbiologic perspective.
Cunha BA
Clin Ther; 1992; 14(3):418-25. PubMed ID: 1638583
[TBL] [Abstract][Full Text] [Related]
16. A combination of amoxicillin and clavulanic acid in the treatment of respiratory tract infections caused by amoxicillin-resistant haemophilus influenzae.
Beeuwkes H; Rutgers VH
Infection; 1981; 9(5):244-8. PubMed ID: 7028635
[TBL] [Abstract][Full Text] [Related]
17. Randomized, multicentre, comparative clinical evaluation of cefuroxime-sulbactam versus amoxicillin-clavulanic acid therapy in the treatment of lower respiratory tract infections.
Pareek A; Pednekar S; Prasad HB; Salagre S; Chandurkar N
J Int Med Res; 2008; 36(6):1293-304. PubMed ID: 19094439
[TBL] [Abstract][Full Text] [Related]
18. Treatment of respiratory tract infections with a combination of amoxycillin and clavulanic acid.
Karachalios GN
Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):647-9. PubMed ID: 4093205
[TBL] [Abstract][Full Text] [Related]
19. [Pediatric suspensions of amoxicillin and clavulanic acid in the treatment of bacterial infections of otorhinolaryngologic importance and the upper respiratory tract].
Amendola F; Natuzzi M; De Mattia D; Schettini F
Minerva Pediatr; 1989 Feb; 41(2):97-103. PubMed ID: 2786988
[TBL] [Abstract][Full Text] [Related]
20. Impact of restricted amoxicillin/clavulanic acid use on Escherichia coli resistance--antibiotic DU90% profiles with bacterial resistance rates: a visual presentation.
Mimica Matanovic S; Bergman U; Vukovic D; Wettermark B; Vlahovic-Palcevski V
Int J Antimicrob Agents; 2010 Oct; 36(4):369-73. PubMed ID: 20688486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
